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Summary
Background.  —  Left  atrial  (LA)  volume  is  an  important  predictor  of  mortality  and  morbidity  after
myocardial  infarction  (MI).  However,  the  process  of  LA  remodelling  has  not  been  extensively
investigated.
Aims. —  Our  purpose  was  to  analyse  the  incidence,  determinants  and  consequences  of  LA
remodelling  in  a  cohort  of  patients  with  a  ﬁrst  anterior  MI  enrolled  in  the  modern  era  of  MI
management.
Methods. —  We  used  data  from  246  patients  with  a  ﬁrst  anterior  MI  who  were  included  in  a
prospective  study  on  left  ventricular  (LV)  remodelling  (REVE-2).  Serial  echocardiographic  studies
were performed  before  discharge  and  at  3  months  and  1  year  after  MI.
Results.  —  LA  volume  increased  from  20.5  ±  5.9  mL/m2 at  baseline  to  24.6  ±  7.4  mL/m2 at  3
months (P  <  0.0001  versus  baseline)  and  25.4  ±  7.6  mL/m2 at  1  year  (P  <  0.0001  versus  base-
line). Patients  with  high  LA  volumes  at  baseline  had  higher  LV  volumes,  decreased  LV  systolic
function,  increased  E/Ea  (early  transmitral  velocity/mitral  annular  early  diastolic  velocity  ratio)
Abbreviations: BNP, B-type natriuretic peptide; E/Ea, early transmitral velocity/mitral annular early diastolic velocity ratio; LA,
eft atrial; LV, left ventricular; LVEDV, left ventricular end-diastolic volume; LVEF, left ventricular ejection fraction; LVESV, left ventricular
nd-systolic volume; MI, myocardial infarction; WMSI, wall motion score index.
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and  increased  B-type  natriuretic  peptide  concentration.  By  multivariable  analysis,  the  sole
independent  predictor  of  change  in  LA  volume  from  baseline  to  1  year  was  peak  creatine  kinase
concentration  (P  <  0.0001).  Patients  with  higher  LA  volumes  at  baseline  were  at  higher  risk  of
cardiovascular  death  or  rehospitalization  for  heart  failure  during  follow-up  (P  =  0.015).
Conclusions.  —  Despite  modern  therapeutic  management,  LA  remodelling  is  common  during
the ﬁrst  3  months  after  anterior  MI.  Patients  with  larger  infarct  size  are  at  greater  risk  of  LA
remodelling after  discharge.
© 2011  Elsevier  Masson  SAS.  All  rights  reserved.
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Résumé
Introduction.  — Le  volume  de  l’oreillette  gauche  est  un  prédicteur  important  de  mortalité  et
morbidité  après  infarctus  du  myocarde.  Cependant,  le  processus  de  remodelage  auriculaire  n’a
fait l’objet  que  de  peu  d’études.
Objectifs.  — Analyser  l’incidence,  les  facteurs  prédictifs,  et  les  conséquences  du  remodelage
auriculaire  gauche  dans  une  cohorte  de  patients  présentant  un  premier  infarctus  antérieur  et
pris en  charge  de  manière  moderne.
Méthodes.  —  Nous  avons  utilisé  les  données  de  246  patients  avec  un  premier  infarctus  antérieur
inclus dans  une  étude  prospective  sur  le  remodelage  ventriculaire  gauche  (REVE-2).  Une
échocardiographie  a  été  réalisée  avant  la  sortie,  après  trois  mois  et  après  un  an.
Résultats.  —  Le  volume  de  l’oreillette  gauche  a  augmenté  de  20,5  ±  5,9  mL/m2 en  base  à
24,6 ±  7,4  mL/m2 à  3  mois  (p  <  0,0001  vs  base)  et  25,4  ±  7,6  mL/m2 à  un  an  (p  <  0,0001  vs  base).
Les patients  avec  un  volume  auriculaire  gauche  élevé  en  base  avaient  des  volumes  ventricu-
laires gauches  plus  élevés,  une  diminution  de  la  fonction  systolique,  ainsi  qu’un  rapport  E/Ea
et un  BNP  plus  élevés.  En  analyse  multivariée,  la  seule  variable  de  base  indépendamment  asso-
ciée au  remodelage  auriculaire  à  un  an  était  le  pic  de  créatine  kinase  (p  <  0,0001).  Les  patients
ayant les  volumes  auriculaires  gauches  les  plus  élevés  en  base  étaient  ceux  avec  le  plus  haut
risque de  décès  cardiovasculaire  ou  de  réhospitalisation  pour  insufﬁsance  cardiaque  durant  le
suivi (p  =  0,015).
Conclusions.  —  Malgré  une  prise  en  charge  moderne,  le  remodelage  auriculaire  gauche  demeure
fréquent lors  des  trois  premiers  mois  après  un  infarctus  antérieur.  Les  patients  à  risque  de
remodelage  auriculaire  après  l’hospitalisation  initiale  sont  les  patients  présentant  un  infarctus
de taille  importante.
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Introduction
Left  atrial  (LA)  volume  is  an  important  predictor  of  mortality
and  morbidity  after  myocardial  infarction  (MI)  [1,2]. How-
ever,  the  process  of  LA  remodelling  (i.e.  dynamic  changes
in  LA  volume  over  time)  has  not  been  extensively  inves-
tigated.  The  purpose  of  this  report  was  to  analyse  the
incidence,  determinants  and  consequences  of  LA  remod-
elling  in  a  cohort  of  patients  with  a  ﬁrst  anterior  MI  enrolled
in  the  modern  era  of  MI  management.
Methods
Study population
The  design  and  inclusion  and  exclusion  criteria  of  the  REVE-2
study  have  been  published  in  detail  elsewhere  [3,4]. Brieﬂy,
it  was  a  prospective  multicentre  study  intended  to  analyse
the  association  of  circulating  biomarkers  with  left  ventricu-
lar  (LV)  remodelling  [5].  We  enrolled  246  patients  with  a  ﬁrst
anterior  wall  Q-wave  MI  from  February  2006  to  September
2008.  Inclusion  criteria  were  hospitalization  within  24  hours
after  symptom  onset  and  a  predischarge  echocardiogram
showing  at  least  three  akinetic  LV  segments  in  the  infarct
r
(
as  droits  réservés.
one.  Exclusion  criteria  were  inadequate  quality  of  the
chocardiographic  image,  life-limiting  non-cardiac  disease,
igniﬁcant  valvular  disease  or  a  prior  Q-wave  MI.  The  ethics
ommittee  of  the  Centre  hospitalier  et  universitaire  de
ille  approved  the  research  protocol,  and  each  patient  pro-
ided  written  informed  consent.  The  protocol  required  serial
chocardiographic  studies  at  hospital  discharge  (day  3  to  day
)  and  at  3  and  12  months  after  MI.
chocardiographic studies
chocardiographic  data  were  obtained  using  commercially
vailable  second  harmonic  imaging  systems.  Echocardio-
rams  were  performed  by  experienced  ultrasonographers
nd  repeated  by  the  same  operator  wherever  possible.
mages  were  recorded  on  optical  disks.  A  standard  imaging
rotocol  was  used,  based  on  apical  four-  and  two-chamber
iews;  two-dimensional  echocardiograms  of  the  LV  short  axis
ere  recorded  from  the  left  parasternal  region  at  three
evels:  mitral  valve,  mid-papillary  muscle  and  apex.  All
chocardiograms  were  analysed  at  the  Lille  core  echo  labo-
atory  as  previously  described  [6].
LV  end-diastolic  volume  (LVEDV),  end-systolic  volume
LVESV)  and  ejection  fraction  (LVEF)  were  calculated  using
 modiﬁed  Simpson’s  rule.  To  evaluate  regional  systolic
2 N.  Lamblin  et  al.
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Table  1  Baseline  characteristics  of  the  study  popula-
tion  (n  =  246  patients).
Age  (years)  57  ±  14
Women 46  (19)
Hypertension 89  (36)
Current  smokers  116  (47)
Diabetes  mellitus  51  (21)
Previous  angina  pectoris  14  (6)
Previous  PCI  6  (2)
Initial  reperfusion  therapy
Primary  PCI
Thrombolysis  alone
Thrombolysis  and  rescue
PCI
128 (52)
28 (11)
59 (24)
No  reperfusion 31  (13)
Multivessel  disease  98  (40)
PCI  during  hospitalization 212  (86)
Heart  failure  (Killip  class  ≥  2)
during  hospitalization
79 (32)
Peak  creatine  kinase
concentration  (IU/L)
2353
[1447—4198]
LVEF  (%) 49  ±  8
Atrial  ﬁbrillation  at  discharge 2  (1)
Medications  at  discharge
Aspirin
Clopidogrel
Beta-blockers
Angiotensin-converting
enzyme  inhibitors
Aldosterone  antagonists
Diuretics
Statins
243  (99)
238  (97)
238  (97)
238  (97)
80 (33)
60 (25)
231  (94)
Data are mean ± standard deviation, number (%) or median
[25th and 75th percentiles]. LVEF: left ventricular ejection
fraction; PCI: percutaneous coronary intervention.
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unction,  the  left  ventricle  was  divided  according  to  a
ixteen-segment  model  as  recommended  by  the  American
ociety  of  Echocardiography  [7].  For  each  segment,  wall
otion  was  scored  from  1  (normal)  to  4  (dyskinetic)  and
he  wall  motion  score  index  (WMSI)  was  derived;  the  normal
MSI  value  is  1.00.  The  LA  volume  was  calculated  using  the
llipsoid  model,  with  the  formula  0.523  (L  ×  D1 ×  D2),  where
 is  the  long  axis  and  D1 and  D2 are  orthogonal  short-axis
imensions  in  parasternal  and  apical  views,  respectively,
s  previously  described  [8].  In  our  core  echo  laboratory,
he  variability  in  the  evaluation  of  LA  volume  was  7.6%.
itral  annular  early  diastolic  velocity  (Ea)  was  measured
ith  pulsed  tissue  Doppler  analysis.  The  sample  volume  was
laced  sequentially  at  the  lateral  and  medial  mitral  annulus.
oth  velocities  were  averaged  to  derive  the  early  transmitral
elocity  (E)/Ea  ratio  as  previously  described  [9].  The  sever-
ty  of  mitral  regurgitation  was  assessed  semiquantitatively
s  previously  described  [10].
easurement of B-type natriuretic peptide
-type  natriuretic  peptide  (BNP)  was  measured  in  plasma
amples  with  a  fully  automated  two-site  sandwich
mmunoassay  on  an  Advia  Centaur  (Siemens  Diagnostic,
urich,  Switzerland).  The  lowest  concentration  measurable
ith  this  assay  with  a  ≤  20%  coefﬁcient  of  variation  is  2.5
g/mL.  The  precision  of  this  technique  is  2.3%  to  4.7%.
linical follow-up
linical  follow-up  was  performed  at  outpatient  visits  or
y  contacting  the  general  practitioner  or  cardiologist.  We
ollected  data  on  death  and  hospitalization  for  heart  fail-
re  (symptoms  of  dyspnea  or  oedema  associated  with
ilateral  rales;  elevated  venous  pressure  or  interstitial  or
lveolar  oedema  on  chest  X-ray;  or  the  addition  of  intra-
enous  diuretics  or  inotropic  medications).  The  investigators
ssessing  the  clinical  endpoints  were  blinded  to  the  echocar-
iographic  data.
tatistical analysis
he  statistical  analysis  was  performed  with  SAS  software
release  9.1;  SAS  Institute,  Cary,  NC,  USA).  Results  are  pre-
ented  as  mean  ±  standard  deviation,  median  with  25th  and
5th  percentiles  or  frequency  expressed  as  a  percentage.
ariables  with  skewed  distribution  were  log-transformed
efore  use  as  continuous  variables  in  statistical  analyses.
e  categorized  LA  volume  into  tertiles  for  the  purposes  of
resentation  and  performed  statistical  analyses  with  LA  vol-
me  as  a  continuous  variable.  Continuous  variables  were
ompared  with  the  paired  or  unpaired  Student’s  t  test.
iscrete  variables  were  compared  using  chi-square  analy-
is.  Independent  correlates  of  change  in  LA  volume  were
dentiﬁed  by  multiple  linear  regression.  Colinearity  was
xcluded  by  means  of  a  correlation  matrix  between  can-
idate  predictors.  Cumulative  survival  was  estimated  using
he  Kaplan-Meier  method;  differences  in  survival  curves
ere  compared  with  a  log-rank  test.  A  P value  <  0.05  was
onsidered  statistically  signiﬁcant.
g
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tesults
he  characteristics  of  the  246  patients  in  the  study  popu-
ation  are  summarized  in  Table  1.  They  had  a  mean  age  of
7  ±  14  years  and  most  (n  =  200)  were  men.  The  index  MI  was
he  ﬁrst  manifestation  of  coronary  artery  disease  in  most
ases.  Initial  reperfusion  therapy  was  primary  percutaneous
oronary  intervention  in  128  patients  and  thrombolysis  in
7  patients.  At  the  baseline  echocardiographic  study  (mean
.0  ±  1.5  days  after  MI),  the  LVEF  was  49  ±  8%.  The  great
ajority  of  patients  were  in  sinus  rhythm.  Nearly  all  patients
eceived  secondary  preventive  treatment.
LA  volume  was  assessed  in  229  patients  at  baseline,
12  patients  at  3  months  and  201  patients  at  1  year
Fig.  1).  LA  volume  increased  from  20.5  ±  5.9  mL/m2 at
aseline  to  24.6  ±  7.4  mL/m2 at  3  months  (P  <  0.0001  ver-
us  baseline),  and  25.4  ±  7.6  mL/m2 at  1  year  (P  <  0.0001
ersus  baseline).  Signiﬁcant  changes  in  other  echocardio-
raphic  variables  and  BNP  concentration  occurred  during
he  1-year  period:  increases  in  LVEDV  (52.3  ±  14.0  mL/m2
o  62.3  ±  18.4  mL/m2;  P  <  0.0001),  LVESV  (26.8  ±  10.5  mL/m2
o  29.0  ±  14.5  mL/m2; P  =  0.0005)  and  LVEF  (49.3  ±  8.5%  to
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Table  2  Associations  of  left  atrial  volume  at  baseline  with  LVEDV,  LVESV,  LVEF,  WMSI,  E/Ea,  BNP  and  the  presence  of
moderate/severe  mitral  regurgitation.
LA  volume  at  baseline  P
1st  tertile
< 17.1  mL/m2
2nd  tertile
17.1—22.2  mL/m2
3rd  tertile
> 22.2  mL/m2
LVEDV  (mL/m2)  47.3  ±  10.2  52.0  ±  11.8  58.8  ±  16.5  <  0.0001
LVESV  (mL/m2)  24.0  ±  7.9  26.4  ±  7.8  31.0  ±  13.8  <  0.0001
LVEF  (%)  49.9  ±  8.3  49.4  ±  7.0  48.4  ±  9.9  0.04
WMSI  1.89  ±  0.14  1.91  ±  0.14  1.93  ±  0.16  0.02
E/Ea  9.5  ±  2.8  10.1  ±  2.9  11.0  ±  3.9  0.01
BNP  concentration  (pg/mL) 90  [55—173]  112  [52—207]  138  [96—250]  0.0001
Moderate/severe  mitral  regurgitation 2  (3) 6  (8)  6  (8)  0.305
Data are mean ± standard deviation, number (%) or median [25th and 75th percentiles]. BNP: B-type natriuretic peptide; E/Ea: early
transmitral velocity/mitral annular early diastolic velocity ratio; LA: left atrial; LVEDV: left ventricular end-diastolic volume; LVEF: left
ventricular ejection fraction; LVESV: left ventricular end-systolic volume; WMSI: wall motion score index.
b
t
s55.2  ±  10.2%;  P  <  0.0001);  decreases  in  WMSI  (1.91  ±  0.15
to  1.64  ±  0.28;  P  <  0.0001),  E/Ea  (10.3  ±  3.5  to  9.6  ±  3.9;
P  =  0.008)  and  BNP  concentration  (110  [62—214]  pg/mL  to
35  [17—77]  pg/mL;  P  <  0.0001);  a  trend  for  an  increase  in
the  proportion  of  patients  with  moderate/severe  mitral
regurgitation  was  also  observed  (5.8%  to  10.1%;  P  =  0.09).
As  shown  in  Table  2,  patients  with  high  LA  volumes  at
w
f
v
Table  3 Baseline  univariate  and  multivariable  predictors  of  ch
up.
Variable Univariate
correlation  coefﬁci
Age  0.037  
Female  sex  —0.038  
Hypertension  0.018  
Current  smokers  0.009  
Diabetes  mellitus  0.048  
Previous  angina  pectoris  0.082  
Primary  PCI  0.113  
Thrombolysis  −0.015  
Multivessel  disease  0.012  
PCI  during  hospitalization  −0.115  
Killip  class  ≥  2  0.173  
Peak  creatine  kinase  concentration  0.339  
Heart  rate  0.249  
Systolic  blood  pressure  0.004  
Diastolic  blood  pressure  −0.036  
LVEF −0.178  
WMSI  0.159  
LVEDV −0.066  
LVESV 0.026
E/Ea −0.043  
Moderate/severe  mitral  regurgitation −0.077 
BNP  concentration 0.047
BNP: B-type natriuretic peptide; E/Ea: early transmitral velocity/mitra
ventricular end-diastolic volume; LVEF: left ventricular ejection fractio
coronary intervention; WMSI: wall motion score index.aseline  had  higher  LV  volumes,  decreased  LV  systolic  func-
ion  and  increased  E/Ea  and  BNP  concentration.
Univariate  and  multivariable  analyses  were  performed  to
earch  for  variables  available  at  baseline  examination  that
ere  associated  with  LA  remodelling  from  baseline  to  1  year
ollow-up  (Table  3).  By  univariate  analysis,  the  change  in  LA
olume  was  positively  associated  with  Killip  class  >  2,  peak
ange  in  left  atrial  volume  from  baseline  to  1-year  follow-
ent
P  Multivariable
beta  coefﬁcient
P
0.615
0.606
0.807
0.906
0.513
0.264
0.123
0.835
0.877
0.116
0.017
<  0.0001  0.266  0.0011
0.0006
0.954
0.630
0.014
0.029
0.370
0.724
0.567
0.293
0.522
l annular early diastolic velocity ratio; LA: left atrial; LVEDV: left
n; LVESV: left ventricular end-systolic volume; PCI: percutaneous
22  N.  Lamblin  et  al.
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Figure 2. Kaplan-Meier curves for cardiovascular death or rehos-
pitalization for heart failure as a function of: A. Left atrial (LA)
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oigure 1. Changes in left atrial (LA) volume from baseline to 1-
ear follow-up. Values are mean ± standard error of the mean.
reatine  kinase  concentration,  heart  rate  and  WMSI,  and
egatively  associated  with  LVEF.  By  multivariable  analysis,
he  sole  independent  predictor  of  change  in  LA  volume  was
eak  creatine  kinase  concentration  (P  <  0.0001).
During  the  3-year  clinical  follow-up,  22  (9%)  patients  died
rom  cardiovascular  causes  or  were  rehospitalized  for  heart
ailure.  As  shown  on  Fig.  2A,  the  patients  with  the  higher
A  volumes  at  baseline  were  those  with  the  higher  risk  of  an
vent  during  follow-up.  Sixteen  (6.5%)  patients  reached  the
ombined  endpoint  after  the  3-month  follow-up;  as  shown
n  Fig.  2B,  the  changes  in  LA  volume  from  baseline  to  3
onths  were  not  associated  with  the  clinical  endpoint.
iscussion
he  prognostic  value  of  LA  volume  in  patients  with  cardio-
ascular  diseases  is  well  established  [11], particularly  in  the
ost-MI  setting  [1,2]. When  assessed  early  after  MI,  LA  vol-
me  is  a  powerful  and  independent  determinant  of  both
id-term  and  long-term  mortality  after  adjustment  for  LV
ystolic  function  and  Doppler-derived  parameters  of  dias-
olic  function  [1,2]. This  is  likely  related  to  the  fact  that
A  volume  is  a  stable  indicator,  reﬂecting  the  duration  and
everity  of  increased  LA  pressure  [11].
Most  studies  reported  to  date,  however,  have  investi-
ated  the  clinical  impact  of  LA  volume  measured  at  a  single
ime  point  (often  early)  and  there  have  been  few  investi-
ations  with  serial  echocardiography  allowing  analysis  of  LA
emodelling  after  MI.  In  one  report  from  the  GISSI-3  Echo
ubstudy  Investigators,  LA  remodelling  was  documented
etween  baseline  and  6-month  follow-up  [12]. However,  at
he  time  when  these  patients  were  included,  modern  reper-
usion  techniques  and  antiremodelling  medications  were  not
ystematically  applied  and,  since  then,  there  have  been
ajor  improvements  in  MI  management  [13,14].  In  an  analy-
is  of  the  VALIANT  Echo  Study,  LA  remodelling  was  observed
p  to  20  months  after  baseline  and  was  associated  with  a
igher  risk  of  clinical  events  [15]; the  patients  in  this  study
a
L
t
polume at baseline; B. Change in LA volume from baseline to 3
onths. T1: 1st tertile; T2: 2nd tertile; T3: 3rd tertile.
ere,  however,  highly  selected  as  they  all  had  MI  with  severe
V  dysfunction.
The  present  study  extends  these  ﬁndings  by  showing
hat  LA  remodelling  is  not  limited  to  patients  with  heart
ailure  after  MI  and  that  nearly  systematic  prescription
f  antiremodelling  drugs  did  not  abolish  this  process.  We
bserved  that  LA  remodelling  occurred  relatively  early  after
I,  with  most  of  the  change  (>  20%  mean  increase)  occur-
ing  before  3  months.  Moreover,  it  is  important  to  be  aware
hat  our  baseline  echocardiography  was  performed  at  day
 and  that  signiﬁcant  LA  enlargement  may  already  have
ccurred  during  the  early  days  of  hospitalization.  Few  vari-
bles  available  at  baseline  hospitalization  were  predictive  of
A  remodelling.  We  found  that  infarct  size,  as  estimated  by
he  peak  creatine  kinase  concentration,  was  the  sole  inde-
endent  determinant  of  further  changes  in  LA  volume.  LA
[[
[
[
[Left  atrial  remodelling  after  MI  
remodelling  is  thus  difﬁcult  to  predict  and,  for  the  time
being,  a  repeat  echocardiographic  assessment  is  needed;
our  results  suggest  that  3  months  would  be  the  optimal  time
point.
In  terms  of  recurrent  clinical  events,  our  results  conﬁrm
the  prognostic  value  of  LA  volume  at  baseline.  In  the  spe-
ciﬁc  setting  of  a  ﬁrst  acute  anterior  MI,  our  data  suggest  that
the  risk  may  manifest  at  a  lower  threshold  than  previously
reported.  Indeed,  most  of  our  patients  who  experienced  a
clinical  event  had  an  LA  volume  less  than  32  mL/m2, the
cut-off  value  that  has  been  validated  in  relation  to  clinical
endpoints  [1,2]. The  change  in  LA  volume  between  baseline
and  3  months  was  not  associated  with  clinical  outcome  after
3  months.  This  ﬁnding  should,  however,  be  taken  with  cau-
tion  due  to  the  lack  of  statistical  power  for  this  analysis;  in  a
population  at  much  higher  risk  [15], LA  remodelling  between
baseline  and  1  month  has  been  associated  with  death  and
hospitalization  for  heart  failure.
Conclusions
Despite  modern  therapeutic  management,  LA  remodelling
remains  common  after  a  ﬁrst  anterior  MI.  This  process
extends  up  to  3  months  after  MI.  The  patients  with  the
greater  risk  of  change  in  LA  volume  after  discharge  are  those
with  the  larger  infarct  size.
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